And a company called Romark Laboratories has come out of nowhere with data on an unheralded anti-parasite drug that seems effective on one hep Cstrain.
Liz Morgan-Lewis, a spokeswoman for the HPA, said it was hard to know how prevalent the new strain of C.difficile was, because comprehensive data was not available.